B CELL HYPERACTIVITY IN AUTOIMMUNITY
自身免疫中的 B 细胞过度活跃
基本信息
- 批准号:6285791
- 负责人:
- 金额:$ 30.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-09-22 至 2006-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the Investigator's abstract): Rheumatoid factors
autologous IgG present in the synovial fluid of patients with rheumatoid
arthritis. High levels of RF-containing immune complexes and/or cryoglobulins
have also been found in patients with microbial infections such as infectious
endocarditis, in individuals presenting with hepatitis C-related essential
mixed cryogloblulinemia, and in Fas/FasL-deficient (lpr/gld) mice. These immune
complexes can deposit in blood vessel walls, fix complement, and thereby
promote the vasculitis and glomerulonephritis associated with these diseases.
Thus the contribution of RF to the effector arm of systemic autoimmune disease
is well documented. Nevertheless, exactly how RF+ B cells become activated, why
RF so frequently present as monoclonal gammopathies, and what role RF+ B cells
might play in the initiation and propagation of the autoimmune cascade are
questions that remain unresolved. The intent of the current application is to
address these questions by using an RF+ B cell receptor transgenic mouse line,
developed from a prototypic MRL/lpr-derived autoantibody, to evaluate the role
RF+ B cells might play in the presentation of autoantigens. Specifically, the
project will be organized to:
(1) determine the ability of monomeric IgG2a and different types of
IgG2a-containing immune complexes to activate RF+ B cells and evaluate the
ability of activated and non-activated RF+ B cells to process and present
autoantigenic epitopes; (2) evaluate the ability of RF+ B cells to stimulate
autoreactive T cells in vitro and determine the specificity of the RF-activated
ART; and (3) assess the ability of RF+ B cells and/or RF -activated ART to
trigger and propagate systemic autoimmune disease. While dealing with RF in
particular, the results of these experiments should be applicable to a more
general understanding of the principles governing self/nonself recognition and
tolerance induction. Moreover, this experimental strategy should also have
direct relevance to human clinical syndromes associated with excessive RF
production.
描述:(改编自研究者摘要):风湿因子
类风湿关节炎患者滑液中存在的自体IgG
关节炎高水平的含RF的免疫复合物和/或cryobacterulins
在微生物感染的患者中也发现,
心内膜炎,在患有丙型肝炎相关基本
混合性冷球蛋白血症和Fas/FasL缺陷(lpr/gld)小鼠。这些免疫
复合物可以存款在血管壁,固定补体,从而
促进与这些疾病相关的血管炎和肾小球肾炎。
因此,RF对系统性自身免疫性疾病的效应臂的贡献
都是有据可查的。然而,RF+ B细胞究竟是如何被激活的,为什么?
RF如此频繁地表现为单克隆丙种球蛋白病,RF+ B细胞的作用是什么
可能在自身免疫级联反应的启动和传播中起作用的是
尚未解决的问题。本申请的目的是
通过使用RF+ B细胞受体转基因小鼠系来解决这些问题,
从原型MRL/lpr衍生的自身抗体开发,以评估
RF+ B细胞可能参与自身抗原的提呈。具体而言是
项目的组织将:
(1)确定单体IgG 2a和不同类型的
含IgG 2a的免疫复合物激活RF+ B细胞并评估RF + B细胞的免疫应答。
活化和非活化RF+ B细胞的加工和呈递能力
自身抗原表位;(2)评估RF+ B细胞刺激
自身反应性T细胞在体外,并确定RF激活的特异性
ART;和(3)评估RF+ B细胞和/或RF活化的ART的能力,
引发和传播系统性自身免疫性疾病。在处理RF时,
特别是,这些实验的结果应该适用于更多的
对自我/非自我识别原则的一般理解,
耐受诱导此外,这一实验策略还应具有
与过量RF相关的人类临床综合征直接相关
生产
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann Marshak-Rothstein其他文献
Ann Marshak-Rothstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann Marshak-Rothstein', 18)}}的其他基金
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
TLR、II 型 IFN 和 III 型 IFN 在小鼠自身炎症模型中的作用
- 批准号:
10576930 - 财政年份:2021
- 资助金额:
$ 30.97万 - 项目类别:
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
TLR、II 型 IFN 和 III 型 IFN 在小鼠自身炎症模型中的作用
- 批准号:
10375346 - 财政年份:2021
- 资助金额:
$ 30.97万 - 项目类别:
Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus
TLR9 缺陷和 FasL 促进皮肤狼疮的机制
- 批准号:
9752064 - 财政年份:2019
- 资助金额:
$ 30.97万 - 项目类别:
Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus
TLR9 缺陷和 FasL 促进皮肤狼疮的机制
- 批准号:
9884735 - 财政年份:2019
- 资助金额:
$ 30.97万 - 项目类别:
Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement
BCR/TLR7 和 BCR/TLR9 共同参与的不同功能结果
- 批准号:
9228925 - 财政年份:2015
- 资助金额:
$ 30.97万 - 项目类别:
Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement
BCR/TLR7 和 BCR/TLR9 共同参与的不同功能结果
- 批准号:
9033830 - 财政年份:2015
- 资助金额:
$ 30.97万 - 项目类别:
Activation of B Cells by Host Toll-Like Receptor Ligands
宿主 Toll 样受体配体激活 B 细胞
- 批准号:
8504902 - 财政年份:2013
- 资助金额:
$ 30.97万 - 项目类别:
Activation of B Cells by Host Toll-Like Receptor Ligands
宿主 Toll 样受体配体激活 B 细胞
- 批准号:
8378438 - 财政年份:2012
- 资助金额:
$ 30.97万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 30.97万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 30.97万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 30.97万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 30.97万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 30.97万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 30.97万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 30.97万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 30.97万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 30.97万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 30.97万 - 项目类别:
Discovery Grants Program - Individual